RxDoctor Payments Data

Robert Garza, MD

Plastic and Reconstructive Surgery · Nashville, TNNPI 1841406063

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,174 of the $5,568 with a category attached, or 75.0%. 16 manufacturers reported payments, led by Elutia, Inc. at 28.0% of the total. 2025 is the largest year on record at $2,297, 5.6 times the $411 reported in 2019.

$5,568in general payments, 2019–2025

Across 126 payments — averaging $44.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elutia, Inc.$2K
  • Smith+Nephew$1K
  • AbbVie$845
  • Integra Lifesciences Corporation$389
  • Biocomposites Inc$345
  • Sientra, Inc.$314
  • plus $1K from 10 others

What the payments were for

  • Speaking & faculty fees$1,06819%
  • Food & beverage$4,17475%
  • Other$3266%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,568 in reported general payments places this provider in the 70th percentile of 77 plastic and reconstructive surgery providers in Tennessee.

See all plastic and reconstructive surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$277,736
Medicare patients
150
Services billed
728

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen39$278
Cephalexin16$114
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$47

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →